epinastine

Subscribe to Selected New Research on epinastine

31 relevant articles (6 outcomes, 9 trials/studies) found for this Drug

Description: RN given refers parent cpd

Also Known As:

3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine; Flurinol; Promeco brand of epinastine hydrochloride; WAL 80; WAL 801; WAL 801 CL; WAL 801CL; WAL-80 Cl; epinastine hydrochloride

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Azoles: 224

Imidazoles: 94

epinastine: 31

3-Ring Heterocyclic Compounds

Dibenzazepines

epinastine: 31

Experts

1.	Schiffman, Rhett M: 2 articles (01/2004 - 01/2004)
2.	Whitcup, Scott M: 2 articles (01/2004 - 01/2004)
3.	Abelson, Mark B: 2 articles (01/2004 - 01/2004)
4.	Townsend, William D: 1 article (06/2007)
5.	Bensch, George: 1 article (06/2007)
6.	Rosenwasser, Lanny J: 1 article (06/2007)
7.	Mah, Francis S: 1 article (06/2007)
8.	Greiner, Jack V: 1 article (06/2007)
9.	Torkildsen, Gail L: 1 article (04/2007)
10.	Workman, D Andrew: 1 article (04/2007)

Related Diseases

1.	Pruritus (Itching) 08/01/2004 - "Epinastine is indicated for the prevention of itching associated with allergic conjunctivitis" 01/01/2004 - "Mean severity scores for the following signs and symptoms were significantly lower with epinastine compared with vehicle at all time points after onset and duration challenges: ocular itching (P<0.001); eyelid swelling (P<0.001); conjunctival ( P<0.001), episcleral ( P<0.001), and ciliary hyperemia (P<0.001); and chemosis (P<or=0.009)" 01/01/2004 - "Epinastine-treated patients reported significantly less ocular itching than those receiving vehicle (P=0.045); scores for hyperemia were similar between these 2 groups" 10/01/2006 - "OBJECTIVES: This post hoc analysis used data from a previous study to more precisely evaluate the efficacy of olopatadine hydrochloride and epinastine hydrochloride in alleviating various levels of severity of ocular itching and conjunctival redness and to determine whether there were any significant differences in the number of responders to treatment" 10/01/2006 - "On response analysis, for itching, the proportion of responders was significantly greater in the olopatadine group versus the epinastine group 7 minutes after challenge (27 [50.9%] vs 14 [26.4%]; P = 0.016)" Get all the results and reference details, order at left...
2.	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/01/2006 - "Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis." 01/01/2004 - "Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis." 04/01/2007 - "CONCLUSIONS: These healthy adult volunteers with a history of seasonal allergic conjunctivitis had no clinical signs of ocular drying after 4 days of twice-daily treatment with topical epinastine" 01/01/2004 - "CONCLUSIONS: In this CAC model, multiple signs and symptoms of allergic conjunctivitis were significantly reduced by instillation of epinastine compared with vehicle" 12/01/2006 - "Because of its neutral impact on the lacrimal functional unit, epinastine may be an especially good choice for the treatment of allergic conjunctivitis in patients with dry eye disease or in those who are at risk for developing dry eye." Get all the results and reference details, order at left...
3.	Asthma (Bronchial Asthma) 02/01/1998 - "Epinastine has other modes of action apart from its antihistamine activity that may be relevant to its use in asthma." 11/01/2000 - "Although efficacy of H(1) blockers in bronchial asthma is somewhat doubtful, the overall improvement rate in asthmatic patients was significantly higher in epinastine-treated patients (53.7%) compared to those treated with ketotifen (25%)." Get all the results and reference details, order at left...
4.	Urticaria (Hives) 11/01/2000 - "In the clinical application of epinastine, it was shown that this drug is remarkably effective in the treatment of various dermatological diseases, such as chronic urticaria, psoriasis vulgaris and other pruritic dermatoses" Get all the results and reference details, order at left...
5.	Skin Diseases 11/01/2000 - "In the clinical application of epinastine, it was shown that this drug is remarkably effective in the treatment of various dermatological diseases, such as chronic urticaria, psoriasis vulgaris and other pruritic dermatoses" Get all the results and reference details, order at left...
30 Diseases and 31 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	olopatadine (Patanol)
2.	Ketotifen (Ketotifene)
3.	Capsaicin (Zostrix)
4.	Loratadine (Alavert)
5.	Chlorpheniramine (Chlorphenamine)
6.	fexofenadine (Allegra)
7.	azelastine (Optivar)
8.	Antigens
9.	Ophthalmic Solutions (Eye Drops)
10.	Botulinum Toxins (Botulinum Toxin)
43 Drugs and Important Bio-Agents and 27 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>